ANTR5 Antibody is a polyclonal antibody that specifically targets and binds to ANTR5 protein in Arabidopsis thaliana (Mouse-ear cress). This antibody is generated by immunizing rabbits with recombinant Arabidopsis thaliana ANTR5 protein as the immunogen . As a research tool, ANTR5 Antibody enables detection, localization, and functional analysis of ANTR5 protein in experimental systems.
The antibody specifically recognizes the native ANTR5 protein (Uniprot No. Q9FKV1) and is purified using antigen affinity methods to ensure high specificity for the target protein . This antibody is designed for research applications only and should not be used in diagnostic or therapeutic procedures.
ANTR5 Antibody has been validated for several experimental applications, primarily:
These validated applications make the antibody suitable for quantitative protein detection (ELISA) and qualitative analysis of protein expression, molecular weight determination, and post-translational modifications (Western Blot). While these are the validated applications, researchers might explore additional applications after performing their own validation studies.
For optimal performance and stability of ANTR5 Antibody, follow these storage and handling recommendations:
Upon receipt, store the antibody at -20°C or -80°C
Avoid repeated freeze-thaw cycles as this can degrade antibody quality
The antibody is provided in liquid form with a preservative buffer containing 0.03% Proclin 300 and 50% Glycerol in 0.01M PBS, pH 7.4
Working aliquots should be prepared to minimize freeze-thaw cycles
When handling the antibody, use sterile pipette tips and sterile microcentrifuge tubes
Wear gloves to prevent contamination and protein degradation from skin contact
Similar to general antibody handling practices, maintaining cold chain conditions during transportation and avoiding prolonged exposure to room temperature will help preserve antibody activity and specificity .
For optimal Western blot results with ANTR5 Antibody, consider the following methodological approaches:
Sample Preparation:
Extract plant proteins using an appropriate buffer that preserves protein integrity
Add protease inhibitors to prevent protein degradation
Denature proteins completely using standard SDS-PAGE sample buffer with heat treatment
Blocking and Antibody Incubation:
Test different blocking agents (5% non-fat milk, 5% BSA, or commercial blocking buffers)
Start with a 1:200 dilution of ANTR5 Antibody as recommended , then optimize based on results
Incubate primary antibody at 4°C overnight for better sensitivity and specificity
Use TBS-T with 0.1% Tween-20 for washing steps
Detection System:
Choose an appropriate HRP-conjugated secondary anti-rabbit antibody
Consider using enhanced chemiluminescence (ECL) for detection
For quantitative analysis, consider digital imaging systems with exposure optimization
Validation Controls:
Include positive control (Arabidopsis thaliana extracts)
Include negative control (non-plant sample)
Perform a peptide competition assay by pre-incubating the antibody with its immunizing peptide
This approach mirrors standard protocols used for other plant antibodies, similar to the Western blot analysis shown for other antibodies in the literature .
Including appropriate controls is crucial for interpreting results with ANTR5 Antibody:
Positive Controls:
Arabidopsis thaliana wild-type tissues known to express ANTR5
Recombinant ANTR5 protein expressed in a heterologous system
Previously validated samples with confirmed ANTR5 expression
Negative Controls:
Tissues from ANTR5 knockout/knockdown plants (if available)
Non-plant tissues or samples from organisms lacking ANTR5 homologs
Secondary antibody-only controls to assess non-specific binding
Peptide Competition/Blocking Controls:
Loading Controls:
Include detection of housekeeping proteins (e.g., actin, tubulin) to normalize expression levels
Use total protein staining methods (e.g., Ponceau S) to verify equal loading
These controls help distinguish specific signals from non-specific background and validate that observed signals truly represent ANTR5 protein, similar to validation methods used for other antibodies in research .
Sample preparation significantly impacts the success of ANTR5 detection in plant tissues:
Extraction Buffers:
Use buffer systems that maintain protein stability (e.g., Tris-HCl pH 7.5-8.0 with 150mM NaCl)
Include detergents appropriate for membrane proteins if ANTR5 has membrane associations
Add protease inhibitors to prevent degradation during extraction
Tissue Processing:
Fresh tissue yields better results than stored samples
Flash-freezing in liquid nitrogen followed by mechanical disruption (grinding) preserves protein integrity
Centrifugation steps should be optimized to separate cellular debris while retaining the protein fraction of interest
Fixation for Immunohistochemistry:
If using ANTR5 Antibody for tissue localization, fixation methods impact epitope accessibility
Test both aldehyde-based (e.g., 4% paraformaldehyde) and alcohol-based fixatives
Consider antigen retrieval methods if fixation reduces antibody binding
Protein Denaturation:
For Western blotting, complete denaturation in SDS-containing buffer with heating (95-100°C for 5 minutes)
For native conditions (e.g., immunoprecipitation), use milder non-ionic detergents and avoid heating
Optimizing these parameters will improve detection sensitivity and specificity, as demonstrated in protocols for other plant antibodies and protein detection methods.
When encountering weak signals or non-specific binding with ANTR5 Antibody, consider these troubleshooting approaches:
For Weak Signals:
| Parameter | Adjustment | Rationale |
|---|---|---|
| Antibody concentration | Increase from 1:200 to 1:100 or 1:50 | Higher concentration may improve detection of low-abundance targets |
| Incubation time | Extend to overnight at 4°C | Allows more complete antibody-antigen binding |
| Protein loading | Increase amount loaded | Ensures detectable target protein levels |
| Detection system | Switch to more sensitive ECL substrate | Amplifies signal from low-abundance proteins |
| Sample preparation | Enrich for target protein fraction | Concentrates the protein of interest |
For Non-specific Signals:
| Parameter | Adjustment | Rationale |
|---|---|---|
| Blocking conditions | Increase blocking time/concentration | Reduces non-specific binding sites |
| Wash stringency | Increase wash duration/detergent | Removes weakly bound antibody |
| Antibody dilution | Increase dilution (1:300-1:500) | Reduces excess antibody contributing to background |
| Blocking agent | Try different blockers (milk vs. BSA) | Different blockers perform better with different antibodies |
| Pre-adsorption | Pre-incubate antibody with non-target tissues | Removes antibodies binding to cross-reactive epitopes |
Additional Considerations:
Verify protein extraction efficiency with total protein stains
Check for protein degradation with fresh samples and additional protease inhibitors
Consider epitope masking that might occur due to protein folding or interactions
Test alternative membrane types for Western blotting (PVDF vs. nitrocellulose)
This systematic approach to optimization follows standard troubleshooting practices for immunoassays and has been effective for other antibodies in research settings .
Validating ANTR5 Antibody cross-reactivity with other plant species requires a strategic approach:
Sequence Homology Analysis:
Perform bioinformatic analysis of the immunogen sequence (residues used to generate the antibody) across potential target species
Higher sequence homology suggests higher likelihood of cross-reactivity
Focus on conserved domains or regions within the ANTR5 protein
Western Blot Validation:
Test protein extracts from candidate plant species in parallel with Arabidopsis controls
Begin with closely related species in the Brassicaceae family
Verify that detected bands match the expected molecular weight of ANTR5 homologs
Confirm specificity with peptide competition assays
Immunoprecipitation Followed by Mass Spectrometry:
Use ANTR5 Antibody to immunoprecipitate potential cross-reactive proteins
Identify captured proteins by mass spectrometry
Compare identified proteins to known ANTR5 homologs
Validation Using Transgenic Systems:
Express the ANTR5 homolog from the target species in a heterologous system
Test antibody binding to the expressed protein
Compare binding efficiency to that of Arabidopsis ANTR5
This methodical approach is similar to the validation strategies used for other antibodies across species, such as those demonstrated for the Nav1.5 antibody across different mammalian systems .
For quantitative analysis of ANTR5 expression using ANTR5 Antibody, consider these methodological approaches:
Quantitative Western Blotting:
Use digital imaging systems with linear detection range
Include calibration standards with known concentrations
Normalize to loading controls (housekeeping proteins or total protein stains)
Analyze band intensity using appropriate software (ImageJ, etc.)
| Sample preparation | Detection method | Normalization | Software analysis |
|---|---|---|---|
| Standardized protein extraction | Chemiluminescence with digital capture | Total protein normalization (Ponceau S) | ImageJ densitometry |
| Bradford-quantified lysates | Near-infrared fluorescence detection | Housekeeping protein controls | Proprietary analysis software |
| Serial dilutions for standard curve | Low-fluorescence PVDF membranes | Recombinant protein standards | Statistical validation (ANOVA) |
Quantitative ELISA:
Develop a sandwich ELISA using ANTR5 Antibody
Generate standard curves with recombinant ANTR5 protein
Ensure samples fall within the linear range of detection
Calculate absolute concentrations based on standard curves
Immunohistochemistry with Digital Image Analysis:
Use consistent staining protocols and imaging parameters
Apply digital image analysis to quantify signal intensity
Compare relative expression levels across tissues or treatments
Include internal reference standards in each experiment
Flow Cytometry for Protoplasts:
Label plant protoplasts with ANTR5 Antibody
Quantify fluorescence intensity per cell
Analyze population distributions and mean fluorescence intensity
These quantitative approaches mirror those used in antibody-based quantification of other proteins, incorporating standardization and calibration methods to ensure reliable comparative analyses .
ANTR5 Antibody can be employed in several methodologies to investigate protein-protein interactions:
Co-Immunoprecipitation (Co-IP):
Use ANTR5 Antibody to precipitate ANTR5 protein and associated complexes
Identify interacting partners through subsequent Western blotting or mass spectrometry
Compare results under different physiological conditions to identify dynamic interactions
Include appropriate controls (IgG control, lysates without antibody) to confirm specificity
Proximity Ligation Assay (PLA):
Combine ANTR5 Antibody with antibodies against potential interacting partners
Visualize and quantify interactions at the subcellular level
This technique detects proteins in close proximity (<40 nm), suggesting direct interaction
Pull-down Assays with Validation:
Use ANTR5 Antibody to validate interactions identified through other methods
Confirm specificity of interactions by competition with excess antigen
Test interactions under different buffer conditions to assess strength and specificity
Immunofluorescence Co-localization:
Perform double immunolabeling with ANTR5 Antibody and antibodies against potential partners
Quantify co-localization using appropriate statistical methods
Use high-resolution microscopy (confocal, STED) for detailed spatial analysis
These approaches are similar to interaction studies performed with other antibodies, such as those described for cardiac sodium channels in the search results , adapted to plant cell biology contexts.
Understanding the epitope recognized by ANTR5 Antibody provides valuable insights into antibody functionality:
Importance of Epitope Mapping:
Reveals the specific region of ANTR5 protein recognized by the antibody
Helps predict potential cross-reactivity with related proteins
Informs experimental design when studying protein domains or post-translational modifications
Assists in interpreting negative results (epitope might be masked in certain conditions)
Mapping Techniques:
Peptide array analysis using overlapping peptides from ANTR5 sequence
Mutagenesis studies to identify critical binding residues
Hydrogen-deuterium exchange mass spectrometry to identify protected regions
X-ray crystallography of antibody-antigen complexes (for detailed structural analysis)
Practical Applications of Epitope Knowledge:
Evaluate accessibility of the epitope in different experimental conditions
Design blocking peptides for specificity controls
Predict effects of protein conformational changes on antibody binding
Understand potential limitations in certain applications (e.g., non-denaturing conditions)
Epitope mapping approaches similar to those used for clinical antibody development can be adapted for research antibodies like ANTR5 Antibody, as demonstrated in antibody characterization studies .
Post-translational modifications (PTMs) can significantly impact ANTR5 Antibody binding, with important experimental implications:
Potential Effects of PTMs on Antibody Recognition:
Phosphorylation, glycosylation, or other modifications may directly block antibody binding sites
PTMs can induce conformational changes that indirectly affect epitope accessibility
Some PTMs might create new epitopes not recognized by the antibody
Certain modifications might enhance antibody binding through increased epitope exposure
Experimental Approaches to Address PTM Interference:
Compare antibody binding under conditions that preserve or remove PTMs
Use phosphatase or glycosidase treatments to remove specific modifications
Combine ANTR5 Antibody with modification-specific antibodies in sequential or parallel detection
Develop validation assays using recombinant ANTR5 with and without specific modifications
Interpreting Results with PTM Considerations:
Variable detection across samples may reflect differential modification states
Absence of signal may indicate modification-based epitope masking rather than absence of protein
Multiple bands on Western blots might represent differently modified forms of ANTR5
This consideration of PTM effects on antibody binding is important for accurate interpretation of experimental results, similar to methodological considerations in protein detection systems for other research antibodies .
Researchers should consider the relative advantages of antibody-based detection versus genetic tagging when studying ANTR5:
| Parameter | ANTR5 Antibody | Genetic Tagging (GFP, FLAG, etc.) |
|---|---|---|
| Detection of endogenous protein | Detects native protein at physiological levels | Requires genetic modification, potential artifacts |
| Spatiotemporal resolution | Limited by antibody specificity and sensitivity | High specificity based on genetic fusion |
| Live-cell imaging | Not suitable for live imaging | Enables real-time observation with fluorescent tags |
| Technical complexity | Requires optimization of immunodetection protocols | Requires successful genetic transformation |
| Post-translational modifications | Detects native modifications | Tag may interfere with some modifications |
| Protein interactions | May disrupt some protein interactions during IP | Tag may interfere with some protein interactions |
| Species applicability | Limited by cross-reactivity | Requires transformation protocols for each species |
| Quantification accuracy | Dependent on antibody linearity and specificity | Often provides more consistent quantification |
Complementary approaches combining antibody detection of native ANTR5 with tagged versions can provide validation and extended experimental capabilities, similar to complementary approaches used in other protein studies .
Rigorous validation of ANTR5 Antibody using genetic knockout or knockdown approaches follows these best practices:
Experimental Design for Validation:
Compare wild-type plants with confirmed ANTR5 knockout/knockdown lines
Include heterozygous plants as intermediate expression controls
Analyze multiple independent knockout/knockdown lines to rule out off-target effects
Process all samples identically to eliminate technical variables
Critical Controls:
Include loading controls to normalize protein amounts
Process wild-type and knockout samples in parallel
Include positive controls for antibody functionality
Test multiple tissues where ANTR5 is expressed at different levels
Analysis and Interpretation:
Complete absence of signal in knockout lines confirms high specificity
Reduced signal proportional to knockdown efficiency supports specificity
Persistent bands in verified knockout lines suggest cross-reactivity
Quantify signal reduction relative to mRNA reduction in knockdown lines
Addressing Partial Validation Results:
If residual signal exists in knockout lines, perform peptide competition assays
Consider mass spectrometry to identify proteins detected in knockout samples
Evaluate potential isoforms or homologs that might be detected
This rigorous validation approach follows standard practices in antibody characterization as demonstrated in similar validation studies for other research antibodies .